Skip to main content
. 2022 Dec 21;12:22069. doi: 10.1038/s41598-022-26547-7

Table 4.

Bivariate distribution of patient characteristics according to their multidrug resistance status.

Characteristic MDR−
N = 7141
(58.40%)
MDR+
N = 5081
(41.60%)
Overall
N = 12221
(100%)
p-value2
Sex 0.019
Female 328 (55%) 265 (45%) 593 (100%)
Male 366 (62%) 224 (38%) 590 (100%)
Age 40 (28,58) 41 (28,62) 41 (28,60) 0.300
Age group 0.031
Under 5 12 (44%) 15 (56%) 27 (100%)
5–14 33 (67%) 16 (33%) 49 (100%)
15–24 49 (51%) 48 (49%) 97 (100%)
25–44 280 (63%) 162 (37%) 442 (100%)
45–59 128 (61%) 83 (39%) 211 (100%)
60 + 176 (55%) 143 (45%) 319 (100%)
Hospitalization status < 0.001
Inpatient 544 (55%) 443 (45%) 987 (100%)
Outpatient 170 (72%) 65 (28%) 235 (100%)
Isolated bacteria
Acinetobacter spp. 27 (55%) 22 (45%) 49 (100%)
Citrobacter spp. 2 (100%) 0 (0%) 2 (100%)
Corynebacterium spp. 2 (67%) 1 (33%) 3 (100%)
Enterococcus spp. 0 (0%) 2 (100%) 2 (100%)
Enterobacter spp. 31 (46%) 36 (54%) 67 (100%)
Escherichia spp. 89 (44%) 112 (56%) 201 (100%)
Gardnerella spp. 0 (0%) 1 (100%) 1 (100%)
Klebsiella spp. 171 (51%) 163 (49%) 334 (100%)
Micrococcus spp. 0 (0%) 2 (100%) 2 (100%)
Moraxella spp. 198 (75%) 66 (25%) 264 (100%)
Pantoea spp. 1 (50%) 1 (50%) 2 (100%)
Photobacterium spp. 0 (0%) 1 (100%) 1 (100%)
Proteus spp. 8 (57%) 6 (43%) 14 (100%)
Providencia spp. 1 (100%) 0 (0%) 1 (100%)
Pseudomonas spp. 125 (81%) 29 (19%) 154 (100%)
Raoultella spp. 6 (55%) 5 (45%) 11 (100%)
Salmonella spp. 3 (60%) 2 (40%) 5 (100%)
Serratia spp. 3 (75%) 1 (25%) 4 (100%)
Shewanella spp. 1 (100%) 0 (0%) 1 (100%)
Sphingomonas spp. 0 (0%) 1 (100%) 1 (100%)
Staphylococcus spp. 41 (44%) 53 (56%) 94 (100%)
Streptococcus spp. 5 (56%) 4 (44%) 9 (100%)

1n (%); Median (IQR); 2Pearson's Chi-squared test; Kruskal–Wallis rank sum test.